Tumor suppressor gene NGX6 induces changes in protein expression profiles in colon cancer HT-29 cells

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 7, 2012, Pages 584-590

  Li, Yu ^a,c   Luo, Yuan ^b   Wang, Xiaoyan ^a   Shen, Shourong ^a   Yu, Haibo ^a   Yang, Jing ^a   Su, Zheng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c HUNAN CANCER HOSPITAL   (China)

Author keywords

colon cancer; differential in gel electrophoresis; mass spectrometry; NGX6

Indexed keywords

MEMBRANE PROTEIN; PROTEOME; TMEM8B PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BIOLOGICAL MODEL; CELL STRAIN HT29; COLON TUMOR; GENETIC TRANSFECTION; GENETICS; HUMAN; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; PROTEOMICS; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; COLONIC NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HT29 CELLS; HUMANS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84863427662     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms042     Document Type: Article

References (29)

1. Yang JB, Bin LH, Li ZH, Zhang XH, Qian J, Zhang BC and Zhou M, et al. Refined localization and cloning of a novel putative tumor suppressor gene associated with nasopharyngeal carcinoma on chromosome 9p21-22. Clin J Cancer 2000, 19: 6-9.
2. Zhang XM, Wang XY, Sheng SR, Wang JR and Li J. Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer. World J Gastroenterol 2003, 9: 1729-1733.
3. Guo Q, Wu M, Lian P, Liao M, Xiao Z, Wang X and Shen S. Synergistic effect of indomethacin and NGX6 on proliferation and invasion by human colorectal cancer cells through modulation of the Wnt/beta-catenin signaling pathway. Mol Cell Biochem 2009, 330: 71-81.
4. Guo Q, Shen S, Liao M, Lian P and Wang X. NGX6 inhibits cell invasion and adhesion through suppression of Wnt/beta-catenin signal pathway in colon cancer. Acta Biochim Biophys Sin 2010, 42: 450-456.
5. Trepel J, Mollapour M, Giaccone G and Neckers L. Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 2010, 10: 537-549.
6. Emoto K, Yamada Y, Sawada H, Fujimoto H, Ueno M, Takayama T and Kamada K, et al. Annexin II overexpression correlates with stromal tenascin-C overexpression: A prognostic marker in colorectal carcinoma. Cancer 2001, 92: 1419-1426.
7. Juneja J and Casey PJ. Role of G12 proteins in oncogenesis and metastasis. Br J Pharmacol 2009, 158: 32-40.
8. Liu RZ, Graham K, Glubrecht DD, Germain DR, Mackey JR and Godbout R. Association of FABP5 expression with poor survival in triple-negative breast cancer: Implication for retinoic acid therapy. Am J Pathol 2011, 178: 997-1008.
9. Morgan E, Kannan-Thulasiraman P and Noy N. Involvement of fatty acid binding protein 5 and PPARb/d in prostate cancer cell growth. PPAR Res 2010, 2010. pii: 234629.
10. Fang LY, Wong TY, Chiang WF and Chen YL. Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma. J Oral Pathol Med 2010, 39: 342-348.
11. Hahn M, Li W, Yu C, Rahmani M, Dent P and Grant S. Rapamycin and UCN-01synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1/MEK/ERK, Akt, and JNK signal transduction pathways. Mol Cancer Ther 2005, 4: 457-470.
12. Yu XM, Shen G, Neckers L, Blake H, Holzbeierlein J, Cronk B and Blagg BS. Hsp90 inhibitors identified from a library of novobiocin analogues. J Am Chem Soc 2005, 127: 12778-12779.
13. Ma Y, Lakshmikanthan V, Lewis RW and Kumar MV. Sensitization of TRAIL- Resistant cells by inhibition of heat shock protein 90 with low-type P53 tumor suppressor protein. J Mol Cancer Ther 2006, 5: 170-178.
14. Hwang M, Moretti L and Lu B. HSP90 inhibitors: Multi-targeted antitumor effects and novel combinatorial therapeutic approaches in cancer therapy. Curr Med Chem 2009, 16: 3081-3092.
15. Basso AD, Solit DB, Chiosis G, Giri B, Tsichlis P and Rosen N. Akt forms an intracellular complex with heat shock protein 90 and Cdc37 and is destabilized by inhibitions of Hsp90 function. J Biol Chem 2002, 277: 39858-39866.
16. Pratt WB, Galiqniana MD, Harrell JM and DeFranco DB. Role of Hsp90 and the Hsp-bingding immunophilins in signaling protein movement. Cell Signal 2004, 16: 857-872.
17. Wang XY, Wu MH, Liu F, Li Y, Li N, Li GY and Shen SR. Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells. Mol Cell Biochem 2010, 345: 283-290.
18. Liu F, Sheng SR, Wang XY, Wang XY, Peng Y, Liao MT and Guo Q. Effects of NGX6 on the transcriptional activation of b-catenin/TCF/LEF in Wnt/b-catenin signal pathway. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2007, 32: 985-991.
19. Wang L, Ma J, Li J, Li X, Zhang Q, Peng S and Peng C, et al. NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells. J Cell Biochem 2005, 95: 64-73.
20. Singh P, Wu H, Clark C and Owlia A. Annexin II binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogenous gastrins on colon cancer and intestinal epithelial cells. Oncogene 2007, 26: 425-440.
21. Duncan R, Carpenter B, Main LC, Telfer C and Murray GI. Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 2008, 98: 426-433.
22. Umar S, Sarkar S, Cowey S and Singh P. Activation of NF-kappaB is required for mediating proliferative and antiapoptotic effects of progastrin on proximal colonic crypts of mice, in vivo. Oncogene 2008, 27: 5599-5611.
23. Cervantes D, Crosby C and Xiang Y. Arrestin orchestrates crosstalk between G proteinocoupled, receptors to modulate the spatiotemporal activation of ERK MAPK. Cirs Res 2010, 106: 79-88.
24. Brzezianska E and Pastuszak-Lewandoska D. A minireview: The role of MAPK/ERK and PI3k/Akt pathways in thyroid follicular cell-dericed neoplasm. Front Biosci 2011, 16: 422-439.
25. Wolfrum C. Cytoplasmic fatty acid binding protein sensing fatty acids for peroxisome proliferator activated receptor activation. Cell Mol Life Sci 2007, 64: 2465-2476.
26. Lawrie LC, Dundas SR, Curran S and Murray GI. Liver fatty acid binding protein expression in colorectal neoplasia. Br J Cancer 2004, 90: 1955-1960.
27. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H and Fields JZ, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009, 69: 3382-3389.
28. O'Dwyer D, Ralton LD, O'Shea A and Murray GI. The proteomics of colorectal cancer: Identification of a protein signature associated with prognosis. PLoS One 2011, 6: E27718.
29. Hope NR and Murray GI. The expression profile of RNA-binding proteins in primary and metastatic colorectal cancer: Relationship of heterogeneous nuclear ribonucleo-proteins with prognosis. Hum Pathol 2011, 42: 393-402.